'/%3E%3C/svg%3E%0A){kind=small}
At Prothena, we feel incredibly grateful to be able to hear firsthand from patients and their caregivers, and to share their wisdom with others. These stories fuel our work each and every day, and continue to remind us of the power of connection and comradery. We know that patients and caregivers often find hope in […]
This year marked the 40th annual International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD), held from April 1-5 in Vienna, Austria. Prothenians attended the conference, joining experts from around the globe who are dedicated to advancing the science and therapy for neurodegenerative diseases. The conference was a hub of innovation, focusing on the latest research […]
Earlier this month, we had the privilege of hearing firsthand from Isabelle Lousada about her journey to an AL amyloidosis diagnosis nearly 30 years ago and her successful stem cell transplant. After achieving complete remission, Isabelle founded the Amyloidosis Research Consortium (ARC) with the goal of uniting different stakeholders to improve outcomes for patients with […]
At Prothena, we feel fortunate to hear from patients whose stories inspire us to continue to innovate for those who are in dire need of new treatment options. Each story fuels our commitment to keep patients and their needs at the forefront of our efforts. We are equally grateful for our relationships with advocacy organizations, […]
Prothena recently reported fourth quarter and full year 2024 financial results, another successful year of progress in our effort to address unmet needs for the millions of patients and their loved ones that are affected by devastating, life-threatening diseases caused by protein dysregulation. With many of our clinical programs nearing significant inflection points in 2025, […]
February 28 marks Rare Disease Day, a time to raise awareness and generate change for the 300 million people worldwide living with a rare disease, along with their families and caregivers. This year’s theme, “more than you can imagine,” inspired us at Prothena to dream beyond the ordinary. We asked a few Prothenians, “What […]
February 11 marks International Day of Women and Girls in Science. Last year, Donna-Lee Destouche, Head of Clinical Trial Management at Prothena, shared advice on inspiring the next generation of female leaders in STEM. Today, we’re honored to hear from Chi Johnson, Associate Director of Facilities and Environment Health & Safety (EH&S) at Prothena. Chi’s […]
The prevalence and impact of Alzheimer’s disease varies by sex, race and ethnicity. In fact, according to the Alzheimer’s Association, nearly two-thirds of people living with Alzheimer’s disease are women. Black Americans are nearly twice as likely as White Americans to develop Alzheimer’s disease or another dementia, and Hispanic Americans are 1.5 times as likely. […]
This summer we shared the powerful story of LuPita, currently living with dementia. Today we are honored to introduce Jessica, LuPita’s daughter and care partner, in honor of November marking National Family Caregivers Month. Hear firsthand from Jessica on how she decided to take on the vital role, the importance of taking care of oneself […]
This month, we’re excited to hear from the newest member of our leadership team at Prothena! In September, Chad Swanson was appointed as Prothena’s new Chief Development Officer. A neuropharmacologist with over 20 years industry experience, Chad joined Prothena as Senior Vice President and Head of Clinical Development in January 2023. In his new role, […]